For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Pacific Biosciences of California Inc (NASDAQ: PACB) was $2.17 for the day, up 34.26% from the previous closing price of $1.62. In other words, the price has increased by $34.26 from its previous closing price. On the day, 38.67 million shares were traded. PACB stock price reached its highest trading level at $2.24 during the session, while it also had its lowest trading level at $1.635.
Ratios:
Our analysis of PACB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.36 and its Current Ratio is at 9.28. In the meantime, Its Debt-to-Equity ratio is 1.44 whereas as Long-Term Debt/Eq ratio is at 1.42.
Goldman Downgraded its Buy to Neutral on April 18, 2024, whereas the target price for the stock was revised from $7 to $2.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 20 ’24 when Farmer Michele sold 5,275 shares for $2.03 per share. The transaction valued at 10,708 led to the insider holds 211,941 shares of the business.
Meline David W bought 40,000 shares of PACB for $176,160 on Mar 06 ’24. The Director now owns 40,000 shares after completing the transaction at $4.40 per share. On Mar 04 ’24, another insider, HENRY CHRISTIAN O, who serves as the insider of the company, sold 14,177 shares for $4.87 each. As a result, the insider received 69,056 and left with 2,596,670 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACB now has a Market Capitalization of 592374272 and an Enterprise Value of 961826048. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.96 while its Price-to-Book (P/B) ratio in mrq is 0.91. Its current Enterprise Value per Revenue stands at 4.799 whereas that against EBITDA is -3.404.
Stock Price History:
The Beta on a monthly basis for PACB is 2.06, which has changed by -0.8412582 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, PACB has reached a high of $14.55, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is 26.20%, while the 200-Day Moving Average is calculated to be -58.11%.
Shares Statistics:
PACB traded an average of 11.00M shares per day over the past three months and 10797370 shares per day over the past ten days. A total of 267.74M shares are outstanding, with a floating share count of 264.11M. Insiders hold about 3.03% of the company’s shares, while institutions hold 92.40% stake in the company. Shares short for PACB as of 1719532800 were 56468818 with a Short Ratio of 5.13, compared to 1717113600 on 54251756. Therefore, it implies a Short% of Shares Outstanding of 56468818 and a Short% of Float of 23.879998999999998.
